Steroid Forum: This is a discussion on PCT and Sustanon within the Anabolic Steroids forums, part of the extensive steroid information at MESO-Rx; I realize Sust lasts longer in the system complicating PCT. Any thoughts on when to start PCT? Three, four weeks ...
I realize Sust lasts longer in the system complicating PCT. Any thoughts on when to start PCT? Three, four weeks after the last shot? Using Clomid and Nolva, any thoughts on dosages or front loading?
And after PCT, when's the earliest one could go back on gear?
Cycle: 500mg Sust/week for 10-12 weeks. Clomid and Nova for PCT, standard Phreezer PCT.
Last edited by enduranceAthlete; 09-21-2006 at 04:07 PM.
If you are running pct for six weeks, I would say that two weeks after last injection would be Ok. But that is just based off of personal experience...
If you are running pct for six weeks, I would say that two weeks after last injection would be Ok. But that is just based off of personal experience...
Okay, thanks. I was thinking three, but maybe I'll split the dif.
Three would probably be ok too. The major concern I would have is to be on the watch for "real" drops in energy, libido, etc. You don't want to spend anymore time on the bottom than you have to. I say "real" because its always a bummer to go from your superhuman steroid strength back to the old clark kent, but that doesn't count as a loss of libido. Levels will have fallen below normal when you feel less than normal. Clomid and nolva can be used for a several months without any danger so, my pct strategy is to be prepared to run until I'm happy with it.
Three would probably be ok too. The major concern I would have is to be on the watch for "real" drops in energy, libido, etc. You don't want to spend anymore time on the bottom than you have to. I say "real" because its always a bummer to go from your superhuman steroid strength back to the old clark kent, but that doesn't count as a loss of libido. Levels will have fallen below normal when you feel less than normal. Clomid and nolva can be used for a several months without any danger so, my pct strategy is to be prepared to run until I'm happy with it.
Be careful Deep vein thrombosis and cataracts have developed in some patients with extended use of tamoxifen citrate
The risks of NOLVADEX therapy include endometrial cancer, DVT, PE, stroke, cataract formation and cataract surgery (See Table 3). In the NSABP P-1 trial, 33 cases of endometrial cancer were observed in the NOLVADEX group vs. 14 in the placebo group (RR=2.48, 95% CI: 1.27-4.92). Deep vein thrombosis was observed in 30 women receiving NOLVADEX vs. 19 in women receiving placebo (RR=1.59, 95% CI: 0.86-2.98). Eighteen cases of pulmonary embolism were observed in the NOLVADEX group vs. 6 in the placebo group (RR=3.01, 95% CI: 1.15-9.27). There were 34 strokes on the NOLVADEX arm and 24 on the placebo arm (RR=1.42; 95% CI: 0.82-2.51). Cataract formation in women without cataracts at baseline was observed in 540 women taking NOLVADEX vs. 483 women receiving placebo (RR=1.13, 95% CI: 1.00-1.28). Cataract surgery (with or without cataracts at baseline) was performed in 201 women taking NOLVADEX vs. 129 women receiving placebo (RR=1.51, 95% CI: 1.21-1.89)
Be careful Deep vein thrombosis and cataracts have developed in some patients with extended use of tamoxifen citrate
The risks of NOLVADEX therapy include endometrial cancer, DVT, PE, stroke, cataract formation and cataract surgery (See Table 3). In the NSABP P-1 trial, 33 cases of endometrial cancer were observed in the NOLVADEX group vs. 14 in the placebo group (RR=2.48, 95% CI: 1.27-4.92). Deep vein thrombosis was observed in 30 women receiving NOLVADEX vs. 19 in women receiving placebo (RR=1.59, 95% CI: 0.86-2.98). Eighteen cases of pulmonary embolism were observed in the NOLVADEX group vs. 6 in the placebo group (RR=3.01, 95% CI: 1.15-9.27). There were 34 strokes on the NOLVADEX arm and 24 on the placebo arm (RR=1.42; 95% CI: 0.82-2.51). Cataract formation in women without cataracts at baseline was observed in 540 women taking NOLVADEX vs. 483 women receiving placebo (RR=1.13, 95% CI: 1.00-1.28). Cataract surgery (with or without cataracts at baseline) was performed in 201 women taking NOLVADEX vs. 129 women receiving placebo (RR=1.51, 95% CI: 1.21-1.89)
PCT for SUST starts 21 days after last inject
How long were these women taking the drug in the trials? Anyone heard of males having developed cataracts or thrombosis as result of taking Nolvadex?
PCT and Sustanon 
Linear Mode
